Chimeric Therapeutics Limited (ASX:CHM) Announces $3.2 Million Entitlement Offer
Chimeric Therapeutics Limited (ASX:CHM) announces a $3.2 million entitlement offer to fund its ongoing cell therapy clinical trials.
Chimeric Therapeutics Limited (ASX:CHM) announces a $3.2 million entitlement offer to fund its ongoing cell therapy clinical trials.
Resolution Minerals (ASX:RML) launches a Bonus Option Offer, allowing eligible shareholders to acquire shares at $0.018, potentially raising $6.95 million for future projects.
Smartpay Holdings Limited (ASX:SMP) receives acquisition proposals from Tyro and a strategic party, initiating due diligence processes.
Carbonxt Group (ASX:CG1) restructures its Black Birch lease, reducing costs by over 50% and securing a 37% premium placement to support growth.
Nine Entertainment Co. (ASX:NEC) appoints Matthew Stanton as CEO, emphasizing his extensive experience and vision for the company’s future.
Zoom2u Technologies (ASX:Z2U) raises $500,000 through a share placement to support Locate2u’s global growth.
PolyNovo Limited (ASX:PNV) announces CEO transition with Dr Robyn Elliott appointed as Acting CEO as it seeks a permanent successor.
De Grey Mining (ASX:DEG) announces its proposed acquisition by Northern Star Resources, recommending shareholders approve the scheme.
Centuria Industrial REIT (ASX:CIP) declares a 4.075 cents per unit distribution for March 2025, outlining key distribution dates.
Pacific Current Group (ASX:PAC) extends its share buy-back closing date and moves interim dividend payment forward to 14 March 2025.